Sfmg LLC Raises Position in McKesson Co. (NYSE:MCK)

Sfmg LLC boosted its stake in shares of McKesson Co. (NYSE:MCK - Free Report) by 23.0% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 2,657 shares of the company's stock after buying an additional 496 shares during the period. Sfmg LLC's holdings in McKesson were worth $1,514,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of MCK. Millstone Evans Group LLC purchased a new position in McKesson during the 4th quarter worth $28,000. Synergy Asset Management LLC bought a new stake in shares of McKesson in the fourth quarter valued at about $32,000. Crews Bank & Trust bought a new position in McKesson during the 4th quarter worth about $33,000. Atala Financial Inc bought a new stake in shares of McKesson in the 4th quarter valued at about $34,000. Finally, RPg Family Wealth Advisory LLC purchased a new position in shares of McKesson in the 3rd quarter worth approximately $31,000. 85.07% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of analysts recently commented on MCK shares. Evercore ISI lifted their target price on shares of McKesson from $650.00 to $675.00 and gave the stock an "outperform" rating in a research note on Thursday, February 6th. Wells Fargo & Company boosted their target price on shares of McKesson from $641.00 to $691.00 and gave the company an "equal weight" rating in a research report on Friday, March 14th. StockNews.com downgraded McKesson from a "strong-buy" rating to a "buy" rating in a research report on Friday, February 14th. Morgan Stanley boosted their price objective on McKesson from $612.00 to $642.00 and gave the company an "overweight" rating in a report on Tuesday, December 17th. Finally, Mizuho initiated coverage on McKesson in a research report on Wednesday, December 4th. They set a "neutral" rating and a $630.00 price target for the company. Two investment analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, McKesson has an average rating of "Moderate Buy" and a consensus price target of $649.36.

Remove Ads

Insider Activity

In related news, CEO Brian S. Tyler sold 8,961 shares of the firm's stock in a transaction that occurred on Friday, February 21st. The shares were sold at an average price of $597.99, for a total value of $5,358,588.39. Following the sale, the chief executive officer now directly owns 60,664 shares of the company's stock, valued at approximately $36,276,465.36. This trade represents a 12.87 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Leann B. Smith sold 188 shares of the company's stock in a transaction that occurred on Wednesday, February 12th. The stock was sold at an average price of $609.59, for a total transaction of $114,602.92. Following the transaction, the executive vice president now directly owns 1,051 shares of the company's stock, valued at $640,679.09. This trade represents a 15.17 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 18,689 shares of company stock valued at $11,187,351 over the last 90 days. Insiders own 0.11% of the company's stock.

McKesson Trading Down 0.2 %

Shares of NYSE:MCK traded down $1.15 during trading on Wednesday, hitting $662.45. 737,849 shares of the stock were exchanged, compared to its average volume of 802,259. McKesson Co. has a 12-month low of $464.42 and a 12-month high of $670.79. The company has a market cap of $83.02 billion, a PE ratio of 30.33, a P/E/G ratio of 1.29 and a beta of 0.52. The company has a fifty day moving average price of $619.05 and a two-hundred day moving average price of $576.50.

McKesson (NYSE:MCK - Get Free Report) last issued its quarterly earnings data on Wednesday, February 5th. The company reported $8.03 earnings per share for the quarter, missing analysts' consensus estimates of $8.60 by ($0.57). McKesson had a negative return on equity of 181.26% and a net margin of 0.82%. Equities research analysts anticipate that McKesson Co. will post 32.77 earnings per share for the current fiscal year.

McKesson Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, April 1st. Stockholders of record on Monday, March 3rd will be issued a dividend of $0.71 per share. The ex-dividend date of this dividend is Monday, March 3rd. This represents a $2.84 dividend on an annualized basis and a dividend yield of 0.43%. McKesson's dividend payout ratio (DPR) is presently 13.00%.

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.